Cleared Special

K163490 - StatStrip Xpress 2 Glucose Hospital Meter System (FDA 510(k) Clearance)

Jan 2017
Decision
25d
Days
Class 2
Risk

K163490 is an FDA 510(k) clearance for the StatStrip Xpress 2 Glucose Hospital Meter System. This device is classified as a Prescription Use Blood Glucose Meter For Near-patient Testing (Class II - Special Controls, product code PZI).

Submitted by Nova Biomedical Corporation (Walham, US). The FDA issued a Cleared decision on January 6, 2017, 25 days after receiving the submission on December 12, 2016.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1345. Intended For Use In Near-patient Testing Settings For In Vitro Diagnostic, Multiple-patient Use For The Quantitative Determination Of Glucose Throughout All Hospital And All Professional Healthcare Settings For Use In Determining Dysglycemia..

Submission Details

510(k) Number K163490 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 12, 2016
Decision Date January 06, 2017
Days to Decision 25 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code PZI — Prescription Use Blood Glucose Meter For Near-patient Testing
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1345
Definition Intended For Use In Near-patient Testing Settings For In Vitro Diagnostic, Multiple-patient Use For The Quantitative Determination Of Glucose Throughout All Hospital And All Professional Healthcare Settings For Use In Determining Dysglycemia.